Carlyle Group Inc.
Institutional investor · Portfolio as of Q2 2025
Top Holdings20 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
STANDARDAERO INC | 152.7M | $4.8B | 96.0% | $27.63 | +14.46% | 3 qtrssince 2024-Q4 | Increased 73 |
SOLENO THERAPEUTICS INC | 860,980 | $72.1M | 1.4% | $26.90 | — | 10 qtrssince 2023-Q1 | Unchanged 0 |
PHATHOM PHARMACEUTICALS INC | 3.5M | $33.5M | 0.7% | $7.87 | +23.69% | 10 qtrssince 2023-Q1 | Unchanged 0 |
PONY AI INC | 2.4M | $31.2M | 0.6% | $15.25 | -10.43% | 3 qtrssince 2024-Q4 | Unchanged 0 |
INVITATION HOMES INC | 477,500 | $15.7M | 0.3% | $27.70 | +15.67% | 10 qtrssince 2023-Q1 | Unchanged 0 |
GETTY IMAGES HOLDINGS INC | 6.2M | $10.3M | 0.2% | $5.55 | -70.09% | 11 qtrssince 2022-Q4 | Unchanged 0 |
CUBESMART | 220,500 | $9.4M | 0.2% | $33.47 | +21.63% | 12 qtrssince 2022-Q3 | Unchanged 0 |
JASPER THERAPEUTICS INC | 1.1M | $5.9M | 0.1% | $18.80 | -70.80% | 10 qtrssince 2023-Q1 | Unchanged 0 |
SMART SH GLOBAL LTD | 3.8M | $4.3M | 0.1% | $1.12 | — | 13 qtrssince 2022-Q2 | Decreased 0 |
HILLEVAX INC | 1.8M | $3.6M | 0.1% | — | — | 10 qtrssince 2023-Q1 | Unchanged 0 |
FORWARD AIR CORP | 107,214 | $3M | 0.1% | $25.15 | 0.00% | 1 qtr | New 39 |
SUNPOWER INC | 1.6M | $2.9M | 0.1% | $1.39 | +24.52% | 8 qtrssince 2023-Q3 | Decreased 0 |
EXICURE INC | 281,636 | $1.9M | 0.0% | $13.76 | -57.18% | 10 qtrssince 2023-Q1 | Unchanged 0 |
| 2.9M | $1.8M | 0.0% | — | — | 10 qtrssince 2023-Q1 | Unchanged 0 | |
Q32 BIO INC | 1.1M | $1.6M | 0.0% | $17.04 | -91.49% | 6 qtrssince 2024-Q1 | Unchanged 0 |
KRISPY KREME INC | 340,748 | $991,577 | 0.0% | $14.92 | -82.24% | 6 qtrssince 2024-Q1 | Unchanged 0 |
N-ABLE INC | 93,732 | $759,229 | 0.0% | $13.07 | -37.87% | 6 qtrssince 2024-Q1 | Unchanged 0 |
ONKURE THERAPEUTICS INC | 269,895 | $642,350 | 0.0% | $8.27 | -70.98% | 3 qtrssince 2024-Q4 | Unchanged 0 |
ROBINHOOD MARKETS INC - A | 2,497 | $233,794 | 0.0% | $83.03 | 0.00% | 1 qtr | New 35 |
NuCana plc | 133,333 | $7,640 | 0.0% | — | — | — | — |
Carlyle Group Inc. manages $5B across 20 positions as of Q2 2025. Top holdings: SARO (96.0%), SLNO (1.4%), PHAT (0.7%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.
Added 2 new positions, exited 5, increased 1, trimmed 2. Top move: SARO (INCREASED, conviction 73). Portfolio: $5.0B across 20 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer